RxDoctor Payments Data

Kristen McGinness, DPM

Foot & Ankle Surgery · Fayetteville, NCNPI 1649566092

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $101,300 of the $122,825 with a category attached, or 82.5%. 34 manufacturers reported payments, led by Smith+Nephew at 56.7% of the total. Reporting peaked in 2019 at $118,379 and has fallen 99.6% since, to $532 in 2025. Among foot & ankle surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$122,825in general payments, 2019–2025

Across 222 payments — averaging $553.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$70K
  • Osiris Therapeutics Inc.$49K
  • Integra Lifesciences Corporation$791
  • Next Science LLC$430
  • Kerecis Limited$406
  • Gramercy Extremity Orthopedics LLC$368
  • plus $2K from 28 others

What the payments were for

  • Speaking & faculty fees$101,30082%
  • Travel & lodging$15,40913%
  • Food & beverage$6,1165%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$122,825 in reported general payments places this provider in the 95th percentile of 196 foot & ankle surgery providers in North Carolina.

See all foot & ankle surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$116,629
Medicare patients
419
Services billed
1,386

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin45$717
Diclofenac Sodium15$708
Ciclopirox32$581
Ammonium Lactate17$417
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$226
Meloxicam25$70

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Fayetteville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →